Appendix B: Panel Roster and Financial Disclosures
Herpes (HHV-8/CMV)
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Gary Holland | David Geffen School of Medicine at University of California, Los Angeles | None | N/A |
| Christine Johnston | University of Washington School of Medicine | Gilead Sciences AbbVie |
Consultant |
| Warren Phipps* | University of Washington School of Medicine | None | N/A |
| Ramya Ramaswami | National Institutes of Health | Celgene/BMS EMD-Serano Janssen CTI Biopharma Merck |
Research Support (paid to institution) |
| Shannon Ross | The University of Alabama at Birmingham Marnix E. Heersink School of Medicine | None | N/A |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Download Guidelines
- Section OnlyPDF (35.09 KB)
- Full GuidelinePDF (5.25 MB)
- Tables OnlyPDF (947.68 KB)